Willemijn S M E Theelen
4PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 17, 2025
Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non-Small Cell Lung Cancer: The Induction Trial.Michiel M Smeenk, Judi N A van Diessen, Thierry N Boellaard
|Dec 13, 2023
A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics.Karlijn Hummelink, Renaud Tissier, Linda J W Bosch
|Jul 19, 2022
PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC.Karlijn Hummelink, Vincent van der Noort, Mirte Muller
|Jul 05, 2020
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.W S M E Theelen, O Krijgsman, K Monkhorst
Pageof 1
Frequent Collaborators
3 joint publications
Kim Monkhorst
3 joint publications
Michel M van den Heuvel
2 joint publications
Karlijn Hummelink
2 joint publications
Vincent van der Noort
2 joint publications
Daniela S Thommen
2 joint publications
Egbert F Smit
2 joint publications
Gerrit A Meijer
1 joint publications
Mirte Muller
1 joint publications
Ferry Lalezari
1 joint publications
Dennis Peters
